Neuland Laboratories Ltd. has expanded its manufacturing capabilities for synthetic peptides. The company offers peptide production using standard sequential chemical peptide syntheses and segment condensation strategies, employing solid phase peptide synthesis procedures, as well as solution phase methods for shorter length peptides, and segment condensation and ligation techniques for very long peptides. M.K. “Mike” Anwer, Ph.D., vice president of R&D at Neuland Labs, said, “Neuland’s ext...